Phase 1 clinical trials of the safety and immunogenicity of adjuvanted plasmid DNA vaccines encoding influenza A virus H5 hemagglutinin
Larry Smith(Vical (United States)), Ronald B. Moss(Vical (United States)), Alice Chu(Vical (United States)), Ernest R. Kitt(Vical (United States)), Robert B. Belshe(Saint Louis University), Martin L. Kabongo(University of California San Diego), Casey E. Dunne(Vical (United States)), Souphaphone Boutsaboualoy(Vical (United States)), Denis Rusalov(Vical (United States)), Luane Reyes(Vical (United States)), Ming Ye(Florida State University), Cindy L. Fisher(Vical (United States)), Roy T. Steigbigel(Stony Brook University), Mohamed Al‐Ibrahim, Jennifer A. Chaplin(Vical (United States)), Alain Rolland(Fonctions Optiques pour les Technologies de l’information), Mary K. Wloch(Vical (United States))
Cited by 142
Related Papers
Developing a Long Short-Term Memory (LSTM) based model for predicting water table depth in agricultural areas
|Journal of Hydrology|2018|824
Global sensitivity analysis in hydrological modeling: Review of concepts, methods, theoretical framework, and applications
|Journal of Hydrology|2015|665
Efficacy Results of a Trial of a Herpes Simplex Vaccine
|New England Journal of Medicine|2012|507
Towards a comprehensive assessment of model structural adequacy
|Water Resources Research|2012|493
Spatiotemporal variations of hydrogeochemistry and its controlling factors in the Gandaki River Basin, Central Himalaya Nepal
|The Science of The Total Environment|2017|283